Gubra A/S
CSE:GUBRA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Empire State Realty Trust Inc
NYSE:ESRT
|
Real Estate
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
DE |
Jumia Technologies AG
NYSE:JMIA
|
Retail
|
|
US |
Tyson Foods Inc
NYSE:TSN
|
Food Products
|
|
US |
Kellogg Co
NYSE:K
|
Food Products
|
|
US |
Alaska Air Group Inc
NYSE:ALK
|
Airlines
|
|
US |
Multiplan Corp
NYSE:MPLN
|
Health Care
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
US |
Lockheed Martin Corp
NYSE:LMT
|
Aerospace & Defense
|
|
US |
Raytheon Technologies Corp
NYSE:RTX
|
Aerospace & Defense
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Shake Shack Inc
NYSE:SHAK
|
Hotels, Restaurants & Leisure
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
114
726
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Empire State Realty Trust Inc
NYSE:ESRT
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Jumia Technologies AG
NYSE:JMIA
|
DE | |
Tyson Foods Inc
NYSE:TSN
|
US | |
Kellogg Co
NYSE:K
|
US | |
Alaska Air Group Inc
NYSE:ALK
|
US | |
Multiplan Corp
NYSE:MPLN
|
US | |
Visa Inc
NYSE:V
|
US | |
Lockheed Martin Corp
NYSE:LMT
|
US | |
Raytheon Technologies Corp
NYSE:RTX
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Shake Shack Inc
NYSE:SHAK
|
US |
This alert will be permanently deleted.
Gubra A/S
Net Issuance of Debt
Gubra A/S
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
G
|
Gubra A/S
CSE:GUBRA
|
Net Issuance of Debt
-kr5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Chemometec A/S
CSE:CHEMM
|
Net Issuance of Debt
-kr1.3m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
Gubra A/S
Glance View
Gubra ApS operates as biotechnology company. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The firm's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.
See Also
What is Gubra A/S's Net Issuance of Debt?
Net Issuance of Debt
-5.1m
DKK
Based on the financial report for Dec 31, 2023, Gubra A/S's Net Issuance of Debt amounts to -5.1m DKK.
What is Gubra A/S's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
88%
Over the last year, the Net Issuance of Debt growth was 88%.